Technology, Patents, and Sport

​
May 13, 2026

This summer, on June 11, the opening game of the FIFA World Cup 2026 is set to take place. Due to an expansion of the number of teams, this will be the largest edition of the tournament so far, involving 48 nations (with England, Germany, Sweden, and the USA providing representation for almost all EIP branches). An enormous number of eyes will be focused not only on some of the world’s most talented athletes, but also—albeit perhaps unintentionally—on the technology behind modern sport. From the equipment to the refereeing, innovation and technology play a crucial role in the world of football, and in sport generally. This article will explore the roles of patents and intellectual property protection in the modernization of sport.

Why "IP and Sports" became a global theme

Each year, the World Intellectual Property Office (WIPO) organizes World IP Day, and this year the theme was: “IP and Sports: Ready, Set, Innovate”. The emphasis on intellectual property as a driver of creativity, innovation, and development in the sporting world is understandable given the expanding role of technology across various aspects of most sports. It is not only about using the latest technology to be competitive at the highest level, but also about increasing fairness in rule enforcement, and improving the experience of the viewers.  

On the pitch: VAR, goal-line technology, and AI player avatars

In football especially, the introduction of technology as a means for assisting the referees has been received with varying degrees of enthusiasm, to say the least. While there are valid reasons for criticizing the way of implementing technologies such as goal-line technology (GLT), Video Assistant Refereeing (VAR), and semi automated offside technology (SAOT), these developments illustrate the technological aspect of football. This summer, the World Cup will also implement AI enabled 3D player avatars, created through body scans of the players, to further enhance the SAOT system. As the technologies develop, the challenge and opportunity will be to deploy them in ways that strengthen officiating accuracy, while preserving the passion and emotions that define the sport.

However, these technologies will not improve organically or in isolation. Improvements are the results of research and development, significant investment, and close collaboration between engineers, entrepreneurs, sport associations, and broadcasters, which is where intellectual property comes in. Developing reliable systems for real‑time sensing, imaging, and data processing requires long development projects and substantial resources, often with no guarantee of immediate success. In this context, patent protection plays an important role by providing inventors and companies with the confidence to invest in innovation, share technology, and continue refining solutions that can improve both the accuracy and the overall experience of the game.

As sport continues to modernize and becomes increasingly technological, the importance of patents and other intellectual property rights grows. Clubs and players across all sports rely heavily on advanced equipment, sensor systems, and data-driven platforms to collect player statistics and performance metrics, allowing for workload analysis, training optimization, and injury risk reduction. These examples include wearable tracking systems used by elite clubs to monitor player workload, and injury prediction platforms, which are both dependent on patented technical solutions. The development and refinement of such technologies, as well as access to the latest solutions, can therefore have a direct impact on player performance, availability, and long term health. As the demand for continued innovation grows, the need for effective patent protection and a thoughtful IP strategy in the sporting world may increase even further.

A patent strategy that keeps pace with the game

In elite sport, as in many other fields, innovation increasingly determines success. Patents and other intellectual property rights constitute a framework for turning technological advances into reliable solutions, and helping to ensure that innovation not only continues, but continues to improve outcomes for fairness, performance, and player welfare. While it may be more captivating to focus on the teams, goals, and winners this summer, one may also consider admiring the innovation and technological development behind the world’s biggest sporting event. From an IP perspective, sport offers an example of how a successful patent strategy actively supports progress, and at EIP we are well prepared to assist with IP matters across all sectors, sport included.

‍

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
The UPC After Three Years: From Experiment to Enforcement Forum
15 July 2026
1,282 cases filed at the UPC in three years: infringement actions have surged while revocation filings stayed flat, easing fears the Court would become a European patent graveyard.
Choosing your SEP battleground: UPC, Germany or UK?
07 June 2026
Choosing the right venue for SEP litigation can significantly influence the outcome of FRAND disputes. This article compares the UPC, German and UK courts, examining their approaches to injunctions, FRAND defences, rate-setting and enforcement. It highlights the strategic advantages of each jurisdiction and explains why many SEP owners are increasingly turning to the UK and UPC as part of their European enforcement strategy.
Synthetic Lethality & AI: IP Strategy in Oncology
26 May 2026
This article explores the resurgence of synthetic lethality in precision oncology, highlighting how AI and machine learning are accelerating the discovery of new therapeutic targets. It also examines growing clinical activity, investment, and the evolving intellectual property challenges shaping this emerging field.
Inside the Visser AI Launch Party
20 May 2026
EIP has officially launched Visser AI®, our hybrid intelligence service for patent drafting and prosecution. Watch the launch film from our event at The Boundary in Shoreditch, and discover how our team of European and US patent attorneys — working with the Patently AI platform , delivers faster, lower-cost work at the EPO, USPTO and beyond.
Protecting Your Startup: Five Intellectual Property Mistakes to Avoid
20 May 2026
Early‑stage startups often focus on product development and fundraising, but overlooking intellectual property (IP) can seriously damage long‑term value. This article explores five common IP mistakes startups make, with a particular focus on patents. It covers the risks of filing patents without professional advice, making public disclosures too early, failing to put enforceable contracts in place with third parties, misunderstanding what patent rights actually provide, and neglecting to develop a clear IP strategy. By highlighting these pitfalls and offering practical guidance, the article helps startups protect their innovations, strengthen their commercial position, and improve their prospects with investors.
Technology, Patents, and Sport
13 May 2026
VAR, goal-line tech, AI 3D player avatars, wearable trackers, the technology reshaping the 2026 World Cup and elite sport rests on a patent system that makes the R&D investment behind it worth taking.
Patents or Trade Secrets? When to Patent in Deep Tech Innovation
11 May 2026
Deep tech companies face unique IP challenges due to long development cycles, high upfront investment, and complex technologies that combine products and processes. This article explores when patents, trade secrets, or a combination of both offer the strongest protection. It explains how factors such as detectability, reverse engineering risk, disclosure to third parties, and employee mobility should shape IP strategy decisions. While patents are often best suited to externally visible or licensable technologies, trade secrets can be highly effective for internal processes and know‑how that deliver performance or cost advantages.
Is Your AI Conversation Privileged?
08 May 2026
Recent US court decisions have, for the first time, tested whether conversations with AI tools can be protected by legal privilege. In United States v. Heppner, a court held that documents generated by a defendant using a public AI platform were not protected by attorney‑client privilege, largely because the AI was not used within a lawyer‑directed relationship and the platform’s terms allowed data retention and disclosure. By contrast, in Warner v. Gilbarco, another court found that AI‑assisted materials created by a self‑represented litigant were protected under the work‑product doctrine, which has a more forgiving standard for waiver.
The evolution of nucleic acid sequencing and what it means for Genomics and IP
27 April 2026
This article outlines the evolution of nucleic acid sequencing, from early Sanger methods to next‑generation and long‑read technologies. The journey from deciphering individual DNA strands to sequencing entire genomes in hours represents one of biotechnology's most impressive transformations. The first human genome, completed through the Human Genome Project, took around 13 years to sequence and cost billions of dollars, whereas modern sequencing methods can now deliver a genome in hours for a few hundred dollars. For those interested in patents and life sciences, understanding the technical evolution of sequencing methods offers insights into how fundamental scientific advances translate into valuable patent portfolios.
World IP Day: The big ideas shaping IP's fastest-moving fields
24 April 2026
For World IP Day, we asked experts of EIP’s five growth areas: Uniphy, Ampliphy, Stratiphy, Codiphy and Quantiphy, to share a quick insight on innovation, IP trends, and what excites them about the future. Each responded to a single, focused question reflecting the role their team plays across EIP.
Meet the EIP team heading to INTA 2026 in London
23 April 2026
INTA's Annual Meeting is coming to London. From 2–6 May 2026, the ExCeL will host more than 10,000 trade mark and IP professionals from over 100 jurisdictions — five days of sessions, side events, and the kind of corridor conversations that turn into lasting working relationships.
National offices report increases in national patent applications throughout Europe: Is the EPO no longer “killing” the national offices?
27 March 2026
National patent offices across Europe have reported a marked increase in patent filings in 2025, breaking with a long‑standing downward trend. Data from Germany, France, Italy, Sweden, Austria, Spain and Norway point to growing activity driven by digital technologies, electrification and increased university participation. At the same time, offices report a rise in self‑drafted and AI‑assisted applications, which may lower barriers to entry but also raise concerns about application quality and examination efficiency.
Make your bio(pharma) IP investment ready
22 March 2026
This recap of our LinkedIn Live series focuses on helping (bio)pharma businesses make their IP investment‑ready. Across three sessions, experts will discuss building resilient IP portfolios, making strategic IP decisions ahead of funding rounds, and what the evolving 2026 (bio)pharma landscape means for long‑term IP strategy.
Are professional guidelines making Patent Attorneys too cautious on AI?
19 February 2026
As AI use accelerates in patent practice, many European patent attorneys remain cautious due to professional AI guidelines from the epi. This article argues those guidelines are not a barrier, but a baseline for responsible use.
Beyond CRISPR: Precision to Platform
23 January 2026
Gene editing is entering a new phase, moving beyond CRISPR-Cas9’s breakthrough but costly, bespoke therapies toward more precise and scalable platforms. While CRISPR-based treatments like Casgevy have proven clinical success, they remain expensive and entangled in ongoing patent disputes over foundational IP. Next-generation tools such as base editing and prime editing avoid double-strand DNA breaks, enabling more accurate corrections and broader therapeutic potential. The field’s focus is now shifting to disease-agnostic platforms that can be adapted across many conditions, improving access and efficiency.